Gametocyte sex ratios in children with asymptomatic, recrudescent, pyrimethamine-sulfadoxine-resistant, Plasmodium falciparum malaria

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 7, 2003, Pages 671-682

  Sowunmi, A ^a,b   Fateye, B A ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR;

ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAMETOCYTE; HUMAN; MALARIA; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIMARY INFECTION; SEX RATIO;

ANTIMALARIALS; AREA UNDER CURVE; CHILD; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; GERM CELLS; HUMANS; MALARIA, FALCIPARUM; MALE; PYRIMETHAMINE; RECURRENCE; SEX RATIO; SULFADOXINE; TIME FACTORS; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0345415576     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803225002381     Document Type: Article

References (38)

1. Anon. (1994). Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers. Atlanta, GA: Centers for Disease Control and Prevention.
2. Boyd, M. F., Stratman-Thomas, W. F. & Kitchen, S. F. (1935). On the relative susceptibility of Anopheles quadrimaculatus to Plasmodium vivax and Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 15, 485-493.
3. Carter, R. & Graves, P. M. (1988). Gametocytes. In Malaria. Principles and Practice of Malariology, Vol. 1, eds Wernsdorfer, W. H. & McGregor, I. pp. 253-305. Edinburgh: Churchill Livingstone.
4. Diourté, Y., Djimdé, A., Doumbo, O. K., Sagara, I., Coulibaly, Y., Dicko, A., Diallo, M., Diakite, M., Cortese, J. F. & Plowe, C. V. (1999). Pyrimethamine-sulphadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. American Journal of Tropical Medicine and Hygiene, 60, 475-478.
5. Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Dicko, A., Su, X.-Z., Nomura, T., Fidock, D. A., Wellems, T. E. & Plowe, C. V. (2001). A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine, 344, 257-263.
6. El Hassan, A. M., Saeed, A. M., Fandrey, J. & Jelkmann, W. (1997). Decreased erythropoietin response in Plasmodium falciparum-associated anaemia. European Journal of Haematology, 59, 299-304.
7. Fidock, D. A., Nomura, T., Talley, A. K., Cooper, R. A., Dzekunov, S. M., Ferdig, M. T., Ursos, L. N., Sidhu, A. B., Naude, B., Deitsch, K. W., Su, X.-Z., Wootton, J. C., Roepe, P. D. & Wellems, T. E. (2000). Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell, 6, 861-871.
8. Handunnetti, S. M., Gunewardena, D. M., Pathirana, P. P. S. L., Ekanayake, K., Weerasinghe, S. & Mendis, K. N. (1996). Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 563-567.
9. Hellgren, U., Angel, V. H., Bergqvist, Y., Arvidsson, A., Forero-Gomez, J. S. & Rombo, L. (1990). Plasma concentrations of sulfadoxine- pyrimethamine and of mefloquine during long-term malaria prophylaxis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 46-49.
10. Hogh, B., Gamage-Mendis, A., Butcher, G. A., Thompson, R., Begtrup, K., Mendis, C., Enosse, S. M., Dgedge, M., Barreto, J., Eling, W. & Sinden, R. E. (1998). The differing impact of chloroquine and pyrimethamine/sulphadoxine upon the infectivity of malaria species to the mosquito vector. American Journal of Tropical Medicine and Hygiene, 58, 176-182.
11. Newton, C. R. J. C., Peshu, N., Kendall, B., Kirkham, F. J., Sowunmi, A., Waruiru, C., Mwangi, I., Murphy, S. & Marsh, K. (1994). Brain swelling and ischaemia in Kenyans with cerebral malaria. Archives of Disease in Childhood, 70, 281-287.
12. Paul, R. E. L., Coulson, T. N., Raibaud, A. & Brey, P. T. (2000). Sex determination in malaria parasites. Science, 287, 128-131.
13. Paul, R. E. L., Brey, P. T. & Robert, V. (2002). Plasmodium sex determination and transmission to mosquitoes. Trends in Parasitology, 18, 32-38.
14. Pickering, J., Read, A. F., Guerrero, S. & West, S. A. (2000). Sex ratio and virulence in two species of lizard malaria parasites. Evolutionary Ecology Research, 2, 171-184.
15. Plowe, C. V., Cortese, J. F., Djimdé, A., Nwanyanwu, O. C., Watkins, W. M., Winstanley, P. A., Estrada-Franco, J. G., Mollinedo, R. E., Avila, J. C., Cespedes, J. L., Carter, D. & Doumbo, O. K. (1997). Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and the epidemiologic patterns of pyrimethamine-sulphadoxine use and resistance. Journal of Infectious Diseases, 176, 1590-1596.
16. Ponnudurai, T., Lensen, A. H. W., Meis, J. F. G. M. & Meuwissen, J. H. E. T. (1986). Synchronization of Plasmodium falciparum gametocytes using automated suspension culture. Parasitology, 93, 263-274.
17. Puta, C. & Manyando, C. (1997). Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Tropical Medicine and International Health, 2, 227-229.
18. Robert, V., Read, A. F., Essong, J., Tchuinkam, T., Mulder, B., Verhave, J. P. & Camevale, P. (1996). Effect of gametocyte sex ratio on infectivity of Plasmodium falciparum to Anopheles gambiae. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 621-624.
19. Robert, V., Awono-Ambene, H. P., Hesran, J.-Y. L. & Trape, J.-F. (2000). Gametocytaemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. American Journal of Tropical Medicine and Hygiene, 62, 210-216.
20. Salako, L. A., Ajayi, F. O., Sowunmi, A. & Walker, O. (1990). Malaria in Nigeria: a revisit. Annals of Tropical Medicine and Parasitology, 84, 435-445.
21. Sarikabuthi, B., Keschamrus, N., Noeypatimanond, S., Weidekamm, E., Leimer, R., Wernsdorfer, W. & Kölle, E. U. (1988). Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects. Acta Tropica, 45, 217-224.
22. Schall, J. J. (1989). The sex ratio of Plasmodium gametocytes. Parasitology, 98, 343-350.
23. Sibley, C. H., Hyde, J. E., Sims, P. F. G., Plowe, C. V., Kublin, J. G., Mberu, E. K., Cowman, A. F., Winstanley, P. A., Watkins, W. M. & Alexis, M. N. (2001). Pyrimethamine-sulphadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology, 17, 582-588.
24. Smalley, M. E. & Sinden, R. E. (1977). Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology, 74, 1-8.
25. Sowunmi, A. (1996). Renal function in acute falciparum malaria. Archives of Disease in Childhood, 74, 293-298.
26. Sowunmi, A. (2002). A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 96, 227-238.
27. Sowunmi, A. (2003). A randomized comparison of chloroquine and chloroquine plus ketotifen in the treatment of acute uncomplicated Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 97, 103-117.
28. Sowunmi, A. & Fateye, B. A. (2003). Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant infections. Annals of Tropical Medicine and Parasitology, 97, 469-479.
29. Sowunmi, A., Adedeji, A. A., Sowunmi, C. O., Falade, C. O., Falade, A. G., Ohaeri, B., Happi, T. C. & Oduola, A. M. J. (2001). Clinical characteristics and disposition kinetics of the hepatomegaly associated with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 95, 1-8.
30. Sutherland, C. J., Alloueche, A., Curtis, J., Drakeley, C. J., Ord, R., Duraisingh, M., Greenwood, B. M., Pinder, M., Warhurst, D. C. & Targett, G. A. T. (2002). Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistant genes. American Journal of Tropical Medicine and Hygiene, 67, 575-585.
31. Tchuinkam, T., Mulder, B., Dechering, K., Stoffels, H., Verhave, J. P., Cot, M., Carnevale, P., Meuwissen, J. E. H. T. & Robert, V. (1993). Experimental infections of Anopheles gambiae with Plasmodium falciparum of naturally infected gametocyte carriers in Cameroon: factors influencing the infectivity to mosquitoes. Tropical Medicine and Parasitology, 44, 271-276.
32. Thomson, D. (1911). A research into the production, life and death of crescents in malignant tertian malaria in treated and untreated cases, by an enumerative method. Annals of Tropical Medicine and Parasitology, 5, 57-82.
33. Trape, J. F. (2001). The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene, 64 (Suppl. 1), 12-17.
34. Wang, P., Lee, C.-S., Bayoumi, R., Djimdé, A., Doumbo, O., Swedberg, G., Dao, L. D., Mshinda, H., Tanner, M., Watkins, W. M., Sims, P. F. G. & Hyde, J. E. (1997). Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origin. Molecular and Biochemical Parasitology, 89, 161-177.
35. West, S. A., Reece, S. E. & Read, A. F. (2001). Evolution of gametocyte sex ratios in malaria and related apicomplexan (protozoan) parasites. Trends in Parasitology, 17, 525-531.
36. West, S. A., Smith, T. G., Nee, S. & Read, A. F. (2002). Fertility insurance and the sex ratios of malaria and related hemosporin blood parasites. Journal of Parasitology, 88, 258-263.
37. White, N. J. & Ho, M. (1992). Pathophysiology of malaria. Advances in Parasitology, 33, 84-175.
38. World Health Organization (2001). The Use of Antimalarial Drugs: Report of a WHO Informal Consultation. Document WHO/CDS/RBM/2001.33. Geneva: WHO.